Health
Transferrin identified as potential contributor to COVID-19 severity – Mirage News
FRANKFURT. The Institute of Medical Virology at Goethe-University, Frankfurt am Main, Germany, and the University of Kent’s School of Biosciences (UK)…
FRANKFURT. The Institute of Medical Virology at Goethe-University, Frankfurt am Main, Germany, and the University of Kent’s School of Biosciences (UK) have identified that a glycoprotein known as transferrin may critically contribute to severe forms of COVID-19.
SARS-CoV-2 is the coronavirus that causes COVID-19. It is currently not known why some individuals develop only mild or no symptoms when infected, whilst others experience severe, life-threatening forms of the disease. However, it is kn…
-
Noosa News16 hours agoWilliam Robinson dies aged 89
-
Business20 hours agoMacquarie tips 14% upside for this ASX tech stock
-
Noosa News17 hours agoTwo-time Archibald Prize-winning painter William Robinson has died, aged 89
-
Business21 hours agoWhat to do with these 3 ASX 200 retail shares after strong price runs: experts